An IR-B-dominant phenotype would presumably be more responsive to insulin and has been associated with a more differentiated phenotype in a number of different tissues, including adipocytes, hepatocytes, and in thyroid cancer (19–21). The gene discussed is INS; the disease is thyroid gland carcinoma.